Literature DB >> 33159883

RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Elizabeth E Palmer1, Renee Carroll2, Marie Shaw2, Raman Kumar2, Andre E Minoche3, Melanie Leffler4, Lucinda Murray4, Rebecca Macintosh5, Dale Wright6, Chris Troedson7, Fiona McKenzie8, Sharron Townshend9, Michelle Ward9, Urwah Nawaz2, Anja Ravine10, Cassandra K Runke11, Erik C Thorland11, Marybeth Hummel12, Nicola Foulds13, Olivier Pichon14, Bertrand Isidor14, Cédric Le Caignec15, Bénédicte Demeer16, Joris Andrieux17, Salam Hadah Albarazi18, Ann Bye19, Rani Sachdev19, Edwin P Kirk19, Mark J Cowley20, Mike Field4, Jozef Gecz21.   

Abstract

Interpretation of the significance of maternally inherited X chromosome variants in males with neurocognitive phenotypes continues to present a challenge to clinical geneticists and diagnostic laboratories. Here we report 14 males from 9 families with duplications at the Xq13.2-q13.3 locus with a common facial phenotype, intellectual disability (ID), distinctive behavioral features, and a seizure disorder in two cases. All tested carrier mothers had normal intelligence. The duplication arose de novo in three mothers where grandparental testing was possible. In one family the duplication segregated with ID across three generations. RLIM is the only gene common to our duplications. However, flanking genes duplicated in some but not all the affected individuals included the brain-expressed genes NEXMIF, SLC16A2, and the long non-coding RNA gene FTX. The contribution of the RLIM-flanking genes to the phenotypes of individuals with different size duplications has not been fully resolved. Missense variants in RLIM have recently been identified to cause X-linked ID in males, with heterozygous females typically having normal intelligence and highly skewed X chromosome inactivation. We detected consistent and significant increase of RLIM mRNA and protein levels in cells derived from seven affected males from five families with the duplication. Subsequent analysis of MDM2, one of the targets of the RLIM E3 ligase activity, showed consistent downregulation in cells from the affected males. All the carrier mothers displayed normal RLIM mRNA levels and had highly skewed X chromosome inactivation. We propose that duplications at Xq13.2-13.3 including RLIM cause a recognizable but mild neurocognitive phenotype in hemizygous males.
Copyright © 2020 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NEXMIF; RLIM; Tonne-Kalscheuer syndrome; Xq13; autism; chromosomal duplication; chromosomal microarray; dosage sensitive gene; intellectual disability; whole genome sequencing

Mesh:

Substances:

Year:  2020        PMID: 33159883      PMCID: PMC7820564          DOI: 10.1016/j.ajhg.2020.10.005

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  KIAA2022 nonsense mutation in a symptomatic female.

Authors:  Laura S Farach; Hope Northrup
Journal:  Am J Med Genet A       Date:  2015-11-17       Impact factor: 2.802

2.  Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features.

Authors:  Yukiko Kuroda; Ikuko Ohashi; Takuya Naruto; Kazumi Ida; Yumi Enomoto; Toshiyuki Saito; Jun-Ichi Nagai; Takahito Wada; Kenji Kurosawa
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

3.  Delineating the Clinical Spectrum Associated With Xq25q26.2 Duplications: Report of 2 Families and Review of the Literature.

Authors:  John C Herriges; Ellen M Arch; Pamela A Burgio; Erin E Baldwin; Danielle LaGrave; Allen N Lamb; Reha M Toydemir
Journal:  J Child Neurol       Date:  2018-11-21       Impact factor: 1.987

4.  X-linked intellectual disability related genes disrupted by balanced X-autosome translocations.

Authors:  Mariana Moysés-Oliveira; Roberta Santos Guilherme; Vera Ayres Meloni; Adriana Di Battista; Claudia Berlim de Mello; Silvia Bragagnolo; Danilo Moretti-Ferreira; Nadezda Kosyakova; Thomas Liehr; Gianna Maria Carvalheira; Maria Isabel Melaragno
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-08-20       Impact factor: 3.568

5.  Skin punch biopsy explant culture for derivation of primary human fibroblasts.

Authors:  Malini Vangipuram; Dennis Ting; Sam Kim; Robert Diaz; Birgitt Schüle
Journal:  J Vis Exp       Date:  2013-07-07       Impact factor: 1.355

6.  De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome.

Authors:  Elizabeth E Palmer; Seungbeom Hong; Fatema Al Zahrani; Mais O Hashem; Fajr A Aleisa; Heba M Jalal Ahmed; Tejaswi Kandula; Rebecca Macintosh; Andre E Minoche; Clare Puttick; Velimir Gayevskiy; Alexander P Drew; Mark J Cowley; Marcel Dinger; Jill A Rosenfeld; Rui Xiao; Megan T Cho; Suliat F Yakubu; Lindsay B Henderson; Maria J Guillen Sacoto; Amber Begtrup; Muddathir Hamad; Marwan Shinawi; Marisa V Andrews; Marilyn C Jones; Kristin Lindstrom; Ruth E Bristol; Saima Kayani; Molly Snyder; María Mercedes Villanueva; Angeles Schteinschnaider; Laurence Faivre; Christel Thauvin; Antonio Vitobello; Tony Roscioli; Edwin P Kirk; Ann Bye; Jasmeen Merzaban; Łukasz Jaremko; Mariusz Jaremko; Rani K Sachdev; Fowzan S Alkuraya; Stefan T Arold
Journal:  Am J Hum Genet       Date:  2019-02-28       Impact factor: 11.025

7.  Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder.

Authors:  Suzanna G M Frints; Aysegul Ozanturk; Germán Rodríguez Criado; Ute Grasshoff; Bas de Hoon; Michael Field; Sylvie Manouvrier-Hanu; Scott E Hickey; Molka Kammoun; Karen W Gripp; Claudia Bauer; Christopher Schroeder; Annick Toutain; Theresa Mihalic Mosher; Benjamin J Kelly; Peter White; Andreas Dufke; Eveline Rentmeester; Sungjin Moon; Daniel C Koboldt; Kees E P van Roozendaal; Hao Hu; Stefan A Haas; Hans-Hilger Ropers; Lucinda Murray; Eric Haan; Marie Shaw; Renee Carroll; Kathryn Friend; Jan Liebelt; Lynne Hobson; Marjan De Rademaeker; Joep Geraedts; Jean-Pierre Fryns; Joris Vermeesch; Martine Raynaud; Olaf Riess; Joost Gribnau; Nicholas Katsanis; Koen Devriendt; Peter Bauer; Jozef Gecz; Christelle Golzio; Cristina Gontan; Vera M Kalscheuer
Journal:  Mol Psychiatry       Date:  2018-05-04       Impact factor: 15.992

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Female mice lacking Ftx lncRNA exhibit impaired X-chromosome inactivation and a microphthalmia-like phenotype.

Authors:  Yusuke Hosoi; Miki Soma; Hirosuke Shiura; Takashi Sado; Hidetoshi Hasuwa; Kuniya Abe; Takashi Kohda; Fumitoshi Ishino; Shin Kobayashi
Journal:  Nat Commun       Date:  2018-09-20       Impact factor: 14.919

10.  RNF12 X-Linked Intellectual Disability Mutations Disrupt E3 Ligase Activity and Neural Differentiation.

Authors:  Francisco Bustos; Anna Segarra-Fas; Viduth K Chaugule; Lennart Brandenburg; Emma Branigan; Rachel Toth; Thomas Macartney; Axel Knebel; Ronald T Hay; Helen Walden; Greg M Findlay
Journal:  Cell Rep       Date:  2018-05-08       Impact factor: 9.423

View more
  2 in total

1.  Yield of array-CGH analysis in Tunisian children with autism spectrum disorder.

Authors:  Fethia Chehbani; Pasquale Tomaiuolo; Chiara Picinelli; Marco Baccarin; Paola Castronovo; Maria Luisa Scattoni; Naoufel Gaddour; Antonio M Persico
Journal:  Mol Genet Genomic Med       Date:  2022-06-27       Impact factor: 2.473

2.  Sequential stabilization of RNF220 by RLIM and ZC4H2 during cerebellum development and Shh-group medulloblastoma progression.

Authors:  Yuwei Li; Chencheng Yang; Huishan Wang; Ling Zhao; Qinghua Kong; Yu Cang; Shuhua Zhao; Longbao Lv; Yan Li; Bingyu Mao; Pengcheng Ma
Journal:  J Mol Cell Biol       Date:  2022-04-05       Impact factor: 8.185

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.